Premium
Programs cite improved access under telehealth initiation to buprenorphine
Author(s) -
Enos Gary
Publication year - 2021
Publication title -
alcoholism and drug abuse weekly
Language(s) - English
Resource type - Journals
eISSN - 1556-7591
pISSN - 1042-1394
DOI - 10.1002/adaw.32985
Subject(s) - buprenorphine , telehealth , opioid use disorder , telemedicine , criminal justice , primary care , covid-19 , medicine , nursing , medical emergency , opioid , family medicine , psychology , political science , health care , criminology , law , receptor , disease , infectious disease (medical specialty)
Two New York primary care programs that offer buprenorphine treatment for opioid use disorder (OUD) are reporting dramatically reduced wait times and other benefits from temporarily relaxed restrictions allowing initiation to treatment after a telemedicine visit. Leaders of the programs say persons exiting the criminal justice system and clients of syringe services programs have been among the main beneficiaries of an exception that was enacted to maintain access to care for OUD during the COVID‐19 crisis.